Product Name
AFG3-like protein 2 (AFG3L2), ELISA Kit
Full Product Name
Rabbit AFG3-like protein 2 (AFG3L2) ELISA Kit
Product Gene Name
AFG3L2 elisa kit
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Request for Current Manual Insert
Request Current Manual
Species Reactivity
Rabbit
Samples
Serum, plasma, Cell Culture Supernatants, body fluid and tissue homogenate
Preparation and Storage
Store all reagents at 2-8 degree C.
Sample Preparation
We suggest pre-experimenting with neat (undiluted) samples, 1:2 or 1:4 dilutions. Please avoid diluting your samples more than 1:10 as it would exceed the dilution limit set for this kit. If the expected concentration of the target is beyond the detection range of the kit, please contact our technical support team
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual.
Other Notes
Small volumes of AFG3L2 elisa kit vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Searchable Terms for AFG3L2 purchase
MBS7230551 is a ready-to-use microwell, strip plate ELISA (enzyme-linked immunosorbent assay) Kit for analyzing the presence of the AFG3-like protein 2 (AFG3L2) ELISA Kit target analytes in
biological samples. The concentration gradients of the kit standards or positive controls render a theoretical kit detection range in biological research samples containing AFG3L2. The ELISA analytical biochemical technique of the MBS7230551 kit is based on AFG3L2 antibody-AFG3L2 antigen interactions (immunosorbency) and an HRP colorimetric detection system to detect AFG3L2 antigen targets in samples. The ELISA Kit is designed to detect native, not recombinant, AFG3L2. Appropriate sample types may include undiluted body fluids and/or tissue homogenates, secretions. Quality control assays assessing reproducibility identified the intra-assay CV (%) and inter-assay CV(%).
NCBI/Uniprot data below describe general gene information for AFG3L2. It may not necessarily be applicable to this product.
NCBI Accession #
NP_006787.2
[Other Products]
NCBI GenBank Nucleotide #
NM_006796.2
[Other Products]
UniProt Secondary Accession #
Q6P1L0[Other Products]
UniProt Related Accession #
Q9Y4W6[Other Products]
Molecular Weight
88,584 Da
NCBI Official Full Name
AFG3-like protein 2
NCBI Official Synonym Full Names
AFG3-like AAA ATPase 2
NCBI Official Symbol
AFG3L2 [Similar Products]
NCBI Official Synonym Symbols
SCA28; SPAX5
[Similar Products]
NCBI Protein Information
AFG3-like protein 2; paraplegin-like protein; ATPase family gene 3, yeast; AFG3 ATPase family gene 3-like 2; AFG3 ATPase family member 3-like 2
UniProt Protein Name
AFG3-like protein 2
UniProt Synonym Protein Names
Paraplegin-like protein
Protein Family
AFG3-like protein
UniProt Gene Name
AFG3L2 [Similar Products]
UniProt Entry Name
AFG32_HUMAN
NCBI Summary for AFG3L2
This gene encodes a protein localized in mitochondria and closely related to paraplegin. The paraplegin gene is responsible for an autosomal recessive form of hereditary spastic paraplegia. This gene is a candidate gene for other hereditary spastic paraplegias or neurodegenerative disorders. [provided by RefSeq, Jul 2008]
UniProt Comments for AFG3L2
AFG3L2: ATP-dependent protease which is essential for axonal development. Defects in AFG3L2 are the cause of spinocerebellar ataxia type 28 (SCA28). It is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA28 is an autosomal dominant cerebellar ataxia (ADCA) with a slow progressive course and no evidence of sensory involvement or cognitive impairment. Defects in AFG3L2 are the cause of spastic ataxia autosomal recessive type 5 (SPAX5). A neurodegenerative disorder characterized by early onset spasticity, peripheral neuropathy, ptosis, oculomotor apraxia, dystonia, cerebellar atrophy, and progressive myoclonic epilepsy.
Protein type: Membrane protein, integral; EC 3.4.24.-; Mitochondrial; Cell development/differentiation; Protease; Chaperone; Membrane protein, multi-pass
Chromosomal Location of Human Ortholog: 18p11
Cellular Component: mitochondrion; mitochondrial inner membrane; integral to membrane
Molecular Function: protein binding; zinc ion binding; metalloendopeptidase activity; unfolded protein binding; ATP binding
Biological Process: myelination; mitochondrial fusion; axonogenesis; cristae formation; righting reflex; death; regulation of multicellular organism growth; nerve development; proteolysis; muscle fiber development; neuromuscular junction development
Disease: Spinocerebellar Ataxia 28; Spastic Ataxia 5, Autosomal Recessive
Research Articles on AFG3L2
1. Identification of a partial AFG3L2 deletion and subsequent functional studies reveal loss of function as the most likely disease mechanism.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.